Skip to main content

Conventional Therapy in Gallbladder Cancer

  • Chapter
  • First Online:
Gallbladder Cancer

Abstract

Gallbladder cancer is the most common malignant tumor of the biliary tract. It has poor outcome with less than 5% overall 5-year survival. There is wide geographical distribution which is due to different genetic susceptibility. The most common risk factors are gallstones in addition to polyps, obesity, pancreaticobiliary maljunction anomalies and gender. Surgery is known to be considered the cornerstone in the management of gallbladder cancer. The management of the patients will mainly depend on the level of invasion of the tumor in the gallbladder wall. For advanced stage cases, some other procedures are performed such as lymphadenectomy, pancreaticoduodenectomy, palliative, chemotherapy, and radiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Qadan M, Kingham P. Technical aspects of gallbladder cancer surgery. Surg Clin North Am. 2016;96:229–45. https://doi.org/10.1016/j.suc2015.12.007.

    Article  Google Scholar 

  2. Dwivedi AND, Jain S, Dixit R. Gallbladder carcinoma: aggressive malignancy with protean loco-regional and distant spread. World J Clin Cases. 2015;3(3):231–44. https://doi.org/10.12998/wjcc.v3.i3.231.

    Article  Google Scholar 

  3. Dixit R, Shukla VK, Pandey M. Molecular alterations in gallbladder cancer. World J Pathol. 2012;1:7.

    Google Scholar 

  4. Dixit R, Pandey M, Tripathi SK, Dwivedi AND, Shukla VK. Comparative analysis of mutational profile of sonic hedgehog gene in gallbladder cancer. Dig Dis Sci. 2017;62(3):708–14. https://doi.org/10.1007/s10620-016-4438-1.

    Article  CAS  Google Scholar 

  5. Soreide K, Guest RV, Harrison EM, Kendall TJ, Garden OJ, Wigmore SJ. Systematic review of management of incidental gallbladder cancer after cholecystectomy. Br J Surg. 2019;106:32–45.

    Article  CAS  Google Scholar 

  6. Dasari BVM, Ionescu MI, Pawlik TM, Hodson J, Sutcliffe RP, Rober K, Muiesan P, Isaac J, Marudanayagam R, Mirza DF. Outcomes of surgical resection of gallbladder cancer in patients presentingjaundice: a systematic review and meta-analysis. J Surg Oncol. 2018;118:477–85. https://doi.org/10.1002/jso.25186.

    Article  Google Scholar 

  7. Dixit R, Srivastava V, Nath G, Shukla M, Pandey M. Helicobacter hepaticus does not increases the risk of gallbladder cancer: results of acase control study and literature review. World J Epidemiol Cancer Prevent. 2017;6(2):9–16.

    Google Scholar 

  8. Pandey M, Mishra RR, Dixit R, Jaiswal R, Shukla M, Nath G. Helicobacter bilis in human gallbladder cancer: results of a case control study and meta analysis. Asian Pac J Cancer Prev. 2010;11(2):343–7.

    Google Scholar 

  9. Nishio H, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253:953–60.

    Article  Google Scholar 

  10. Sakamoto Y, Nara S, Kishi Y, Esaki M, Shimada K, Kokudo N, Kosuge Y. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer. Surgery. 2013;153:795–800.

    Article  Google Scholar 

  11. Verma K, Dixit R, Singh J, Tiwary SK, Khanna AK, Narayan G, Kumar P. Molecular genetics changes in gallbladder carcinoma. Int J Mol Immuno Oncol. 2020;5(2):49–61.

    Google Scholar 

  12. Agarwal AK, Javed A, Kalayarasan R, Sakhuja P. Minimally invasive versus the conventional open surgical approach of a radical cholecystectomy for gallbladder cancer: a retrospective comparative study. HPB. 2015;17:536–41. https://doi.org/10.1111/hpb.12406.

    Article  Google Scholar 

  13. de Aretxabala X, Castillo F, Hepp J, Muñoz S, Vivanco M, Burgos L, Solano N, Rencoret G, Roa I. Gallbladder cancer, who is cured? HPB (Oxford). 2021;23(8):1253–8. https://doi.org/10.1016/j.hpb.2020.12.006.

    Article  Google Scholar 

  14. Roa I, Ibacache G, Muñoz S, de Aretxabala X. Gallbladder cancer in Chile. Pathological characteristics of survival and prognosis factors: analysis of 1366 cases. Am J Clin Pathol. 2014;141:675–82.

    Article  Google Scholar 

  15. Pandey P, Pandey M, Singh KK, Dixit R, Shukla VK. Health related quality of life in patients of the gallbladder cancer with treatment. Int J Biol Med Res. 2017;8(2):5948–53.

    Google Scholar 

  16. Sirohi B, Mitra A, Jagannath P. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer. Future Oncol. 2015;11:1501–9.

    Article  CAS  Google Scholar 

  17. Shindoh J, de Aretxabala X, Aloia T, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg. 2015;261:733–9.

    Article  Google Scholar 

  18. Horkoff MJ, Zubir A, Yuan X, et al. Adverse outcomes after bile spillage in incidental gallbladder cancers. A population -based study. Ann Surg. 2021;273:139–44.

    Article  Google Scholar 

  19. Vega EA, de Aretxabala X, Qiao W, Newhook TE, et al. Comparison of oncological outcomes after open and laparoscopic re-resection of incidental gallbladder cancer. Br J Surg. 2020;107(3):289–300. https://doi.org/10.1002/bjs.1379.

    Article  CAS  Google Scholar 

  20. Aloia TA, Jarufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17:681–90.

    Article  Google Scholar 

  21. Yamashita S, Koay EJ, Passot G, et al. Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: a comprehensive analysis of 362 consecutive patients. Cancer. 2017;123:1354–62.

    Article  CAS  Google Scholar 

  22. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273–81.

    Article  CAS  Google Scholar 

  23. Shroff RT, Javle MM, Xiao L, et al. Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial. JAMA Oncol. 2019;5:824–30.

    Article  Google Scholar 

  24. Lamarca A, Palmer DH, Wasan HS, et al. A randomized phase III, multi-center, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin/5- FU chemotherapy (ASC + mFOLFOX) for patients (pts) with locally advanced/metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy. J Clin Oncol. 2019;37:4003.

    Article  Google Scholar 

  25. Phelip JM, Edeline J, Blanc JF, et al. Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: study protocol for a randomized controlled multicenter phase II/III study. Dig Liver Dis. 2019;51:318–20.

    Article  CAS  Google Scholar 

  26. Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, et al. SWOG So809: a phase II intergroup trial of adjuvant Capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015;33:2617–22. https://doi.org/10.1200/JCO.2014.60.2219.

    Article  CAS  Google Scholar 

  27. Goff LW, Lowery MA, Jordan E, et al. Second-line chemotherapy (CTX) outcomes in advanced biliary cancers (ABC): a retrospective multicenter analysis. J Clin Oncol. 2016;34:437.

    Article  Google Scholar 

  28. Chen C, Feng WM, Zheng YY, Bao Y, Feng M. Intra-arterial chemotherapy improved survival of stage 2-3 gallbladder cancer after curative resection. Onco Targets Ther. 2018;11:2975–9.

    Article  Google Scholar 

  29. Mitin T, Enestvedt CK, Jemal A, Sineshaw HM. Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival. J Natl Cancer Inst. 2017;109.

    Google Scholar 

  30. Kim K, Chie EK, Jang JY, Kim SW, Han SW, Oh DY, et al. Postoperative chemoradiotherapy for gallbladder cancer. Strahlenther Onkol. 2012;188:388–92.

    Article  CAS  Google Scholar 

  31. González ME, Giannini OH, González P, Saldaña B. Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer. Clin Transl Oncol. 2011;13:480–4.

    Article  Google Scholar 

  32. Kim BH, Kwon J, Chie EK, Kim K, Kim YH, Seo DW, et al. Adjuvant chemoradiotherapy is associated with improved survival for patients with resected gallbladder carcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2018;25:255–64.

    Article  Google Scholar 

  33. Müller B, Sola JA, Carcamo M, Ciudad AM, Trujillo C, Cerda B. Adjuvant chemoradiation for resected gallbladder cancer: treatment strategies for one of the leading causes of cancer death in Chilean women. Indian J Cancer. 2013;50:184–8.

    Article  Google Scholar 

  34. Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, et al. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2009;75:150–5.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xabier de Aretxabala .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

de Aretxabala, X., Manriquez, L., Castillo, F. (2023). Conventional Therapy in Gallbladder Cancer. In: Kumar Shukla, V., Pandey, M., Dixit, R. (eds) Gallbladder Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-19-6442-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-6442-8_3

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-6441-1

  • Online ISBN: 978-981-19-6442-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics